Filed: 2/12/2024ACC: 0001172661-24-000711
📋 What this filing means
MONASHEE INVESTMENT MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 44 equity positions with a total reported market value of $566.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
44
Positions
$566.54M
Total AUM (reported)
12.98M
Total Shares
Allocation by class
CORE S&P500 ETF$118.79M21.0%
S&P 500 ETF SHS$118.38M20.9%
VAN FTSE DEV MKT$74.23M13.1%
CORE MSCI EAFE$55.04M9.7%
COM$39.86M7.0%
FTSE EMR MKT ETF$38.76M6.8%
CORE MSCI EMKT$33.42M5.9%
Portfolio Concentration
Top 3$311.40M55.0%
4–10$187.33M33.1%
11–25$49.56M8.7%
Rest$18.26M3.2%
Top 3 weight
55.0%
Top 10 weight
88.0%
Voting Authority Distribution
Total shares with voting rights: 12.98M
Sole
Full voting authority
12.98M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole44
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings44
Rows:
ISHARES TR
SOLEShares248.71K
TypeSH
Market value$118.79M
20.97%
Sole
248.71K
Shared
0.00
None
0.00
VANGUARD INDEX FDS
SOLEShares271.01K
TypeSH
Market value$118.38M
20.89%
Sole
271.01K
Shared
0.00
None
0.00
VANGUARD TAX-MANAGED FDS
SOLEShares1.55M
TypeSH
Market value$74.23M
13.10%
Sole
1.55M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares782.38K
TypeSH
Market value$55.04M
9.72%
Sole
782.38K
Shared
0.00
None
0.00
VANGUARD INTL EQUITY INDEX F
SOLEShares942.96K
TypeSH
Market value$38.76M
6.84%
Sole
942.96K
Shared
0.00
None
0.00
ISHARES INC
SOLEShares660.70K
TypeSH
Market value$33.42M
5.90%
Sole
660.70K
Shared
0.00
None
0.00
ISHARES TR
SOLEShares216.86K
TypeSH
Market value$22.82M
4.03%
Sole
216.86K
Shared
0.00
None
0.00
VANGUARD INDEX FDS
SOLEShares96.06K
TypeSH
Market value$22.79M
4.02%
Sole
96.06K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares191.85K
TypeSH
Market value$7.82M
1.38%
Sole
191.85K
Shared
0.00
None
0.00
AERCAP HOLDINGS NV
SOLEShares90K
TypeSH
Market value$6.69M
1.18%
Sole
90K
Shared
0.00
None
0.00
PG&E CORP
SOLEShares260K
TypeSH
Market value$4.69M
0.83%
Sole
260K
Shared
0.00
None
0.00
KORRO BIO INC
SOLEShares90.81K
TypeSH
Market value$4.35M
0.77%
Sole
90.81K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares175K
TypeSH
Market value$4.04M
0.71%
Sole
175K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares100.21K
TypeSH
Market value$3.97M
0.70%
Sole
100.21K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares350K
TypeSH
Market value$3.93M
0.69%
Sole
350K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares10K
TypeSH
Market value$3.80M
0.67%
Sole
10K
Shared
0.00
None
0.00
LAS VEGAS SANDS CORP
SOLEShares75K
TypeSH
Market value$3.69M
0.65%
Sole
75K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares3.46M
TypeSH
Market value$3.16M
0.56%
Sole
3.46M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares207.50K
TypeSH
Market value$2.95M
0.52%
Sole
207.50K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares70K
TypeSH
Market value$2.95M
0.52%
Sole
70K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares73.95K
TypeSH
Market value$2.70M
0.48%
Sole
73.95K
Shared
0.00
None
0.00
PERMIAN RESOURCES CORP
SOLEShares175.90K
TypeSH
Market value$2.39M
0.42%
Sole
175.90K
Shared
0.00
None
0.00
FLUENCE ENERGY INC
SOLEShares100K
TypeSH
Market value$2.38M
0.42%
Sole
100K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares37.50K
TypeSH
Market value$2.35M
0.42%
Sole
37.50K
Shared
0.00
None
0.00
VESTA REAL ESTATE CORP
SOLEShares55K
TypeSH
Market value$2.18M
0.38%
Sole
55K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | CORE S&P500 ETF | 248.71K | SH | $118.79M 20.97% | 248.71K | 0.00 | 0.00 |
VANGUARD INDEX FDSSOLE | S&P 500 ETF SHS | 271.01K | SH | $118.38M 20.89% | 271.01K | 0.00 | 0.00 |
VANGUARD TAX-MANAGED FDSSOLE | VAN FTSE DEV MKT | 1.55M | SH | $74.23M 13.10% | 1.55M | 0.00 | 0.00 |
ISHARES TRSOLE | CORE MSCI EAFE | 782.38K | SH | $55.04M 9.72% | 782.38K | 0.00 | 0.00 |
VANGUARD INTL EQUITY INDEX FSOLE | FTSE EMR MKT ETF | 942.96K | SH | $38.76M 6.84% | 942.96K | 0.00 | 0.00 |
ISHARES INCSOLE | CORE MSCI EMKT | 660.70K | SH | $33.42M 5.90% | 660.70K | 0.00 | 0.00 |
ISHARES TRSOLE | CORE S&P TTL STK | 216.86K | SH | $22.82M 4.03% | 216.86K | 0.00 | 0.00 |
VANGUARD INDEX FDSSOLE | TOTAL STK MKT | 96.06K | SH | $22.79M 4.02% | 96.06K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 191.85K | SH | $7.82M 1.38% | 191.85K | 0.00 | 0.00 |
AERCAP HOLDINGS NVSOLE | SHS | 90K | SH | $6.69M 1.18% | 90K | 0.00 | 0.00 |
PG&E CORPSOLE | COM | 260K | SH | $4.69M 0.83% | 260K | 0.00 | 0.00 |
KORRO BIO INCSOLE | COM | 90.81K | SH | $4.35M 0.77% | 90.81K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 175K | SH | $4.04M 0.71% | 175K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 100.21K | SH | $3.97M 0.70% | 100.21K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 350K | SH | $3.93M 0.69% | 350K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 10K | SH | $3.80M 0.67% | 10K | 0.00 | 0.00 |
LAS VEGAS SANDS CORPSOLE | COM | 75K | SH | $3.69M 0.65% | 75K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 3.46M | SH | $3.16M 0.56% | 3.46M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | COM | 207.50K | SH | $2.95M 0.52% | 207.50K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 70K | SH | $2.95M 0.52% | 70K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 73.95K | SH | $2.70M 0.48% | 73.95K | 0.00 | 0.00 |
PERMIAN RESOURCES CORPSOLE | CLASS A COM | 175.90K | SH | $2.39M 0.42% | 175.90K | 0.00 | 0.00 |
FLUENCE ENERGY INCSOLE | COM CL A | 100K | SH | $2.38M 0.42% | 100K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 37.50K | SH | $2.35M 0.42% | 37.50K | 0.00 | 0.00 |
VESTA REAL ESTATE CORPSOLE | ADS | 55K | SH | $2.18M 0.38% | 55K | 0.00 | 0.00 |
Page 1 of 2